Merck’s Relative Strength Continues
Published July 18th, 2006 in Technical Analysis Tags: Abbott Labs, ABT, Astrazeneca, AZN, Eli Lilly, investing, JNJ, LLY, Merck, MRK, pharma, relative strength, Schering, SHR, trading.
With the tape being so red, it is always interesting to find pockets of relative strength. One area of strength has been the big pharmas. I’ve already mentioned before that I really like this sector and Merck specifically. So far, Merck has performed brilliantly:
During April, May and June, while the general market indices were falling apart, Merck simply tread water. And by the middle of June it had actually begun to climb up, fighting against the current of the general market.
Some other very high relative strength stocks in this sector are Astrazeneca (AZN), Abbott Labs (ABT), Eli Lilly (LLY), Johnson & Johnson (JNJ), and Schering AG (SHR) [being taken over by Bayer]. Take a look at their charts and you’ll see very similar outpeformance relative to the market.
Abbott Labs, ABT, Astrazeneca, AZN, Eli Lilly, investing, JNJ, LLY, Merck, MRK, pharma, relative strength, Schering, SHR, trading
Enjoyed this? Don't miss the next one, grab the feed or
2 Responses to “Merck’s Relative Strength Continues”
Leave a Reply
Search
Trader’s Narrative is powered by
Hey Babak, are you sure this is a weekly chart? Is this from Stockcharts.com? How do you add the relative performance on top of the chart?
Eyal: nice catch! you’re right it was a daily which I mislabelled. Yes, the chart is from stockcharts.com. To see relative performance, go to the bottom where it says indicators, use price and put in symbol:index (colon means divided by) and then choose the pane above - you can also put it below or behind.